ASP7962 + Placebo

Phase 1Completed
0 watching 0 views this week๐Ÿ’ค Quiet
33
Hype Score

Development Stage

โœ“
Pre-clinical
2
Phase 1
3
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Safety

Conditions

Safety, Tolerability, Pharmacokinetics of ASP7962

Trial Timeline

Nov 1, 2013 โ†’ May 1, 2014

About ASP7962 + Placebo

ASP7962 + Placebo is a phase 1 stage product being developed by Astellas Pharma for Safety. The current trial status is completed. This product is registered under clinical trial identifier NCT01981928. Target conditions include Safety, Tolerability, Pharmacokinetics of ASP7962.

Hype Score Breakdown

Clinical
10
Activity
5
Company
10
Novelty
3
Community
2

Clinical Trials (2)

NCT IDPhaseStatus
NCT02136316Phase 1Completed
NCT01981928Phase 1Completed